Comparison of prognostic systems in cirrhotic patients with hepatic encephalopathy

Comparison of prognostic systems in cirrhotic patients with hepatic encephalopathy

Background/aim: There are various scoring systems for evaluating prognosis in patients hospitalized in intensive care units (ICUs)with hepatic encephalopathy. These include the Child–Turcotte–Pugh (CTP) classification, Model for End-stage Liver Disease (MELD),chronic liver failure–sequential organ failure assessment (CLIF-SOFA), and Acute Physiology and Chronic Health Evaluation II(APACHE II). In this study, we aimed to compare the various scoring systems to determine the best system for showing the prognosisof patients with a prior diagnosis of cirrhosis who were hospitalized for hepatic encephalopathy.Materials and methods: Patients with known cirrhosis hospitalized in the internal medicine ICU of the Adana Numune Educationand Research Hospital with a diagnosis of hepatic encephalopathy were included in the study. Diagnosis and classification of hepaticencephalopathy were done according to the West Haven criteria. The etiology of hepatic encephalopathy was recorded for all patients.APACHE II, CLIF-SOFA, MELD, and CTP scores were calculated for all patients within the first 24 h. Outcomes of patients wererecorded as either discharged or deceased. Demographic and biochemical data, duration of hospitalization, and prognostic factors werecompared for both groups. Area under the receiver operating characteristic curve (AUROC) values were calculated for each scoringsystem.Results: A total of 84 patients were included in the study. The etiologies of encephalopathy were infection (n = 35, 41.7%), varicealbleeding (n = 19, 22.6%), constipation (n = 15, 17.9%), consuming excessive protein (n = 8, 9.5%), hypokalemia (n = 6, 7.1%), andhepatocellular carcinoma (n = 1, 1.2%). Nine patients had grade 1 encephalopathy, 34 patients had grade 2, 27 patients had grade 3, and14 patients had grade 4. AUROC values were 0.986 (0.970–1.003), 0.974 (0.945–1.003), 0.955 (0.915–0.996), and 0.880 (0.800–0.959) forCLIF-SOFA, APACHE II, CTP, and MELD scores, respectively.Conclusion: We found the best prognostic model for patients who were hospitalized in the ICU for hepatic encephalopathy to be CLIFSOFA,followed by APACHE II, CTP, and MELD scores.

___

  • Swaminathan M, Ellul MA, Cross TJ. Hepatic encephalopathy: current challenges and future prospects. Hepat Med 2018; 10: 1-11.
  • Wijdicks EF. Hepatic encephalopathy. N Engl J Med 2016; 375: 1660-1670.
  • Bajaj JS, Cordoba J, Mullen KD, Amodio P, Shawcross DL, Butterworth RF, Morgan MY. Review article: the design of clinical trials in hepatic encephalopathy - an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther 2011; 33: 739-747.
  • Kalafateli M, Zisimopoulos K, Vourli G, Rigamonti C, Goulis J, Manesis E, Manolakopoulos S, Tsochatzis E, Georgiou A, Diamantopoulou G. Prognostic models for survival in patients with stable cirrhosis: a multicenter cohort study. Dig Dis Sci 2017; 62: 1363-1372.
  • Zhou XD, Zhang JY, Liu WY, Wu SJ, Shi KQ, Braddock M, Chen YP, Huang WJ, Zheng MH. Quick chronic liver failuresequential organ failure assessment: an easy-to use scoring model for predicting mortality risk in critically ill cirrhosis patients. Eur J Gastroenterol Hepatol 2017; 29: 698-705.
  • Zhou XD, Chen QF, Zhang MC, Van Poucke S, Liu WY, Lu Y, Shi KQ, Huang WJ, Zheng MH. Scoring model to predict outcome in critically ill cirrhotic patients with acute respiratory failure: comparison with MELD scoring models and CLIFSOFA score. Expert Rev Gastroenterol Hepatol 2017; 11: 857- 864.
  • Zhou XD, Chen QF, Wang ZX, Liu WY, Van Poucke S, Mao Z, Wu SJ, Huang WJ, Zheng MH. Acute circulatory failurechronic liver failure-sequential organ failure assessment score: a novel scoring model for mortality risk prediction in critically ill cirrhotic patients with acute circulatory failure. Gastroenterol Hepatol 2017; 29: 464-471.
  • Elzouki AN, Suliman S, Alhasan R, Abdullah A, Othman M, Badi A. Predicting mortality of patients with cirrhosis admitted to medical intensive care unit: an experience of a single tertiary center. Arab J Gastroenterol 2016; 17: 159-163.
  • Hemida K, Al Swaff RE, Shabana SS, Said H, Ali-Eldin F. Prediction of post-operative mortality in patients with HCVrelated cirrhosis undergoing non-hepatic surgeries. J Clin Diagn Res 2016; 10: OC18-OC21.
  • Radisavljevic MM, Bjelakovic GB, Nagorni AV, Stojanovic MP, Radojkovicn MD, Jovic JZ, Ignjatovic AM, Radisavljevic MM, Simonovic MM. Predictors of mortality in long-term follow-up of patients with terminal alcoholic cirrhosis: is it time to accept remodeled scores? Med Princ Pract 2017; 26: 169-175.
  • Fan X, Wen M, Shen Y, Wang W, Yang X, Yang L. Does adding variceal status to the Child-Turcotte-Pugh score improve its performance in predicting mortality in cirrhosis? Medicine (Baltimore) 2016; 95: e4884.
  • Peeraphatdit T, Naksuk N, Thongprayoon C, Harmsen WS, Therneau TM, Ricci P, Roberts LR, Chaiteerakij R. Prognostic value of model for end-stage liver disease score measurements on a daily basis in critically ill patients with cirrhosis. Mayo Clin Proc 2015; 90: 1196-1206.
  • Dupont B, Delvincourt M, Koné M, du Cheyron D, Ollivier- Hourmand I, Piquet MA, Terzi N, Dao T. Retrospective evaluation of prognostic score performances in cirrhotic patients admitted to an intermediate care unit. Dig Liver Dis 2015; 47: 675-681.
  • Peng Y, Qi X, Dai J, Li H, Guo X. Child-Pugh versus MELD score for predicting the in-hospital mortality of acute uppergastrointestinal bleeding in liver cirrhosis. Int J Clin Exp Med 2015; 8: 751-757.
  • Zhang J, Ye L, Zhang J, Lin M, He S, Mao X, Zhou X, Zhi F. MELD scores and Child-Pugh classifications predict the outcomes of ERCP in cirrhotic patients with choledocholitiasis: a retrospective cohort study. Medicine (Baltimore) 2015; 94: e433.
  • Lee M, Lee JH, Oh S, Jang Y, Lee W, Lee HJ, Yoo JJ, Choi WM, Cho YY, Cho Y. CLIF-SOFA scoring system accurately predicts short-term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis. Liver Int 2015; 35: 46-57.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Ankaferd Blood Stopper with antibiofilm potential successfully inhibits the extracellular matrix degradation enzymes and promotes wound healing of 3T3 fibroblasts in vitro

Tuba BAYGAR, Nurdan SARAÇ, Aysel UĞUR, Rukiye BORAN

Development and testing of a novel symptom assessment scale for Behçet’s disease

Filiz ÖZEL, Fisun ŞENUZUN AYKAR, Gökhan KESER, Aynur Esen TÜREYEN

The effects of preadministration of local anesthetic on pulsed radiofrequency

Meltem UYAR, Tülin ARICI, Mustafa KURÇALOĞLU, Can EYİGÖR, Bora UZUNER, İdris Şevki KÖKEN

Esra Firat OĞUZ, Fatma Meriç YILMAZ, Engin TUTKUN, Ömer Hinç YILMAZ, Müjgan ERCAN, Sevilay SEZER

Faize Elif BAHADIR, Mustafa Kutay KÖROĞLU, Meral YÜKSEL, Feriha ERCAN, Yaşar İnci ALİCAN

Human immunodeficiency virus and tuberculosis coinfection: clinical features and predictors of mortality

Merve ALTINKAYNAK, Fatma GÜMÜŞER, Özlem ALTUNTAŞ AYDIN, Mustafa Haluk VAHABOĞLU, Alper GÜNDÜZ, Dilek YILDIZ SEVGİ, Hayat KUMBASAR KARAOSMANOĞLU, Sibel BÖLÜKÇÜ, Bilgül METE, Ömer Fehmi TABAK

Comparison of prognostic systems in cirrhotic patients with hepatic encephalopathy

Mehmet Suat YALÇIN, Adnan TAŞ, Banu KARA, Bünyamin SARITAŞ

Alp ATASOY, Evrim ÇAKIR, Süleyman AHBAB, Yasemin Erdoğan DÖVENTAŞ, Macit KOLDAŞ, Hayriye Esra ATAOĞLU, Mustafa YENİGÜN

Dr Munir Ahmad BHINDER, Muhammad Yasir ZAHOOR, Haleema SADIA, Muhammad QASIM, Rukhsana PERVEEN, Ghulam Murtaza ANJUM, Muhammad IQBAL, Najeeb ULLAH, Waseem SHEHZAD, Muhammad TARIQ, Ali Muhammad WARYAH

Effect of phosphodiesterase-5 inhibition on joint and muscle damage in rats with adjuvant arthritis

Feriha ERCAN, Faize Elif BAHADIR, Y. İnci ALİCAN, Mustafa Kutay KÖROĞLU, Meral YÜKSEL